AURX
Nuo Therapeutics, Inc.
Set alert
- YTD
- -34.01%
- 1 year
- -42.22%
- Open
- 1.28
- Prev close
- 1.30
- Mkt cap
- 62.96M
- Vol
- 100
- Avg vol
- 4.49K
- EPS
- -0.04
- P/E
- 0.00
More statistics
- Low
- 1.28
- High
- 1.28
News
2 months ago globenewswire.com
Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
D ifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth HOUSTON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage…
5 months ago globenewswire.com
Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
HOUSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company focused on developing and marketing regenerative therapies for…
1 year ago globenewswire.com
Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on…
1 year ago globenewswire.com
Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate…